Annual Cash & Cash Equivalents
$14.21 M
+$9.91 M+230.39%
June 30, 2024
Summary
- As of February 8, 2025, IBIO annual cash & cash equivalents is $14.21 million, with the most recent change of +$9.91 million (+230.39%) on June 30, 2024.
- During the last 3 years, IBIO annual cash & cash equivalents has fallen by -$63.19 million (-81.64%).
- IBIO annual cash & cash equivalents is now -81.64% below its all-time high of $77.40 million, reached on June 30, 2021.
Performance
IBIO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$11.04 M
-$3.17 M-22.32%
September 30, 2024
Summary
- As of February 8, 2025, IBIO quarterly cash and cash equivalents is $11.04 million, with the most recent change of -$3.17 million (-22.32%) on September 30, 2024.
- Over the past year, IBIO quarterly cash and cash equivalents has dropped by -$3.17 million (-22.32%).
- IBIO quarterly cash and cash equivalents is now -87.90% below its all-time high of $91.25 million, reached on December 31, 2020.
Performance
IBIO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
IBIO Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +230.4% | -22.3% |
| 3 y3 years | -81.6% | +68.2% |
| 5 y5 years | +221.4% | +68.2% |
IBIO Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -81.6% | +230.4% | -71.8% | +655.5% |
| 5 y | 5-year | -81.6% | +230.4% | -87.9% | +655.5% |
| alltime | all time | -81.6% | >+9999.0% | -87.9% | >+9999.0% |
IBio Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $11.04 M(-22.3%) |
| Jun 2024 | $14.21 M(+230.4%) | $14.21 M(+168.0%) |
| Mar 2024 | - | $5.30 M(+90.2%) |
| Dec 2023 | - | $2.79 M(+90.8%) |
| Sep 2023 | - | $1.46 M(-66.0%) |
| Jun 2023 | $4.30 M(-81.0%) | $4.30 M(-34.5%) |
| Mar 2023 | - | $6.56 M(+77.5%) |
| Dec 2022 | - | $3.70 M(-62.6%) |
| Sep 2022 | - | $9.89 M(-56.4%) |
| Jun 2022 | $22.68 M(-70.7%) | $22.68 M(-32.8%) |
| Mar 2022 | - | $33.77 M(-13.9%) |
| Dec 2021 | - | $39.20 M(-37.6%) |
| Sep 2021 | - | $62.82 M(-18.8%) |
| Jun 2021 | $77.40 M(+40.4%) | $77.40 M(-8.5%) |
| Mar 2021 | - | $84.63 M(-7.3%) |
| Dec 2020 | - | $91.25 M(+17.7%) |
| Sep 2020 | - | $77.54 M(+40.7%) |
| Jun 2020 | $55.11 M(+1146.6%) | $55.11 M(+448.9%) |
| Mar 2020 | - | $10.04 M(+176.1%) |
| Dec 2019 | - | $3.64 M(+72.9%) |
| Sep 2019 | - | $2.10 M(-52.4%) |
| Jun 2019 | $4.42 M(-72.3%) | $4.42 M(-51.1%) |
| Mar 2019 | - | $9.04 M(-32.4%) |
| Dec 2018 | - | $13.36 M(-16.5%) |
| Sep 2018 | - | $16.01 M(+0.5%) |
| Jun 2018 | $15.93 M(+97.0%) | $15.93 M(+368.9%) |
| Mar 2018 | - | $3.40 M(-53.5%) |
| Dec 2017 | - | $7.31 M(+23.6%) |
| Sep 2017 | - | $5.92 M(-26.9%) |
| Jun 2017 | $8.09 M(-64.9%) | $8.09 M(-34.9%) |
| Mar 2017 | - | $12.42 M(-23.9%) |
| Dec 2016 | - | $16.33 M(-18.8%) |
| Sep 2016 | - | $20.10 M(-12.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2016 | $23.01 M(+142.4%) | $23.01 M(+5.1%) |
| Mar 2016 | - | $21.89 M(+225.2%) |
| Dec 2015 | - | $6.73 M(-19.7%) |
| Sep 2015 | - | $8.38 M(-11.7%) |
| Jun 2015 | $9.49 M(+164.5%) | $9.49 M(+17.5%) |
| Mar 2015 | - | $8.08 M(+9.7%) |
| Dec 2014 | - | $7.36 M(+111.2%) |
| Sep 2014 | - | $3.49 M(-2.9%) |
| Jun 2014 | $3.59 M(-18.7%) | $3.59 M(-17.1%) |
| Mar 2014 | - | $4.33 M(-23.7%) |
| Dec 2013 | - | $5.68 M(+64.9%) |
| Sep 2013 | - | $3.44 M(-22.0%) |
| Jun 2013 | $4.41 M(-21.5%) | $4.41 M(+189.1%) |
| Mar 2013 | - | $1.53 M(-45.8%) |
| Dec 2012 | - | $2.82 M(-34.1%) |
| Sep 2012 | - | $4.28 M(-24.0%) |
| Jun 2012 | $5.62 M(+97.8%) | $5.62 M(-16.4%) |
| Mar 2012 | - | $6.72 M(+978.4%) |
| Dec 2011 | - | $623.50 K(-59.1%) |
| Sep 2011 | - | $1.52 M(-46.4%) |
| Jun 2011 | $2.84 M(+212.5%) | $2.84 M(-25.9%) |
| Mar 2011 | - | $3.84 M(-33.5%) |
| Dec 2010 | - | $5.77 M(+1738.4%) |
| Sep 2010 | - | $313.80 K(-65.5%) |
| Jun 2010 | $909.90 K(-12.4%) | $909.90 K(-39.1%) |
| Mar 2010 | - | $1.50 M(-50.2%) |
| Dec 2009 | - | $3.00 M(-11.1%) |
| Sep 2009 | - | $3.38 M(+225.0%) |
| Jun 2009 | $1.04 M(+5369.5%) | $1.04 M(-26.7%) |
| Mar 2009 | - | $1.42 M(-17.5%) |
| Dec 2008 | - | $1.72 M(-43.1%) |
| Sep 2008 | - | $3.02 M(>+9900.0%) |
| Jun 2008 | $19.00 K(+1.1%) | $19.00 K |
| Jun 2007 | $18.80 K | - |
FAQ
- What is iBio annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for iBio?
- What is iBio annual cash & cash equivalents year-on-year change?
- What is iBio quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for iBio?
- What is iBio quarterly cash and cash equivalents year-on-year change?
What is iBio annual cash & cash equivalents?
The current annual cash & cash equivalents of IBIO is $14.21 M
What is the all time high annual cash & cash equivalents for iBio?
iBio all-time high annual cash & cash equivalents is $77.40 M
What is iBio annual cash & cash equivalents year-on-year change?
Over the past year, IBIO annual cash & cash equivalents has changed by +$9.91 M (+230.39%)
What is iBio quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of IBIO is $11.04 M
What is the all time high quarterly cash and cash equivalents for iBio?
iBio all-time high quarterly cash and cash equivalents is $91.25 M
What is iBio quarterly cash and cash equivalents year-on-year change?
Over the past year, IBIO quarterly cash and cash equivalents has changed by -$3.17 M (-22.32%)